Preparation and In-Vitro Characterization of Crystallo-Co-Agglomerates of Cilnidipine

SR Patel - Journal of Medical and Pharmaceutical Innovation, 2016 - jmedpharm.com
The present invention was aimed to develop pharmaceutically equivalent, stable, cost
effective and quality improved formulation of cilnidipine with enhanced dissolution rate and …

Preparation, characterization and tableting of cilnidipine solid dispersions.

L Hu, W Song, F Niu, K Jiao… - Pakistan Journal of …, 2013 - search.ebscohost.com
Solid dispersion technique has been developed many years for improving solubility of water-
insoluble drugs, aiming to achieve a better oral bioavailability. However, this technique …

[PDF][PDF] Design and characterization of lercanidipinehcl microcrystalline formulation for solubility and dissolution enhancement

GK Derkar, MR Bhat, KH Randive, RM Chimkode - Int J Appl Res Eng, 2016 - ijarse.org
Improved bioavailability is an added advantage for most of the poorly water soluble drugs. In
recent years research work is concentrated on various methods to improve the solubility …

[PDF][PDF] Cilnidipine Nanocrystals, Formulation and evaluation for Optimization of solubility and Dissolution Rate

SA Al Hazzaa, NA Rajab - Iraqi Journal of Pharmaceutical Sciences (P-ISSN …, 2023 - iasj.net
The aim of this study is to formulate and evaluate cilnidipine nanocrystals (CLD NCs) using
solvent antisolvent technology. Cilnidipine has a very low solubility (BCS Class-II drug low …

[HTML][HTML] Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation

SS Deshkar, GR Borde, RN Kale… - International Journal …, 2017 - ncbi.nlm.nih.gov
Materials and Methods: Cilostazol agglomerates were prepared using various polymers with
varying concentration of hydroxypropyl methylcellulose E 50 (HPMC E50), polyvinyl …

Development and characterization of solid dispersion-based orodispersible tablets of cilnidipine

M Mohana, S Vijayalakshmi - Beni-Suef University Journal of Basic and …, 2022 - Springer
Background Cilnidipine, a calcium channel blocker, is the first-line drug for hypertension and
belongs to Biopharmaceutics Classification System II. To mitigate its extensive first-pass …

[PDF][PDF] An improvement of micromeritic properties and dissolution behaviors of carvedilol spherical agglomerates crystallized in presence of inutec SP1

A Tapas, P Kawtikwar, D Sakarkar - Turk J Pharm Sci, 2012 - academia.edu
The objective of the present work was to improve micromeritic properties and dissolution
rate of a poorly water soluble drug, carvedilol, by spherical agglomeration in presence of …

Influence of Different Stabilizers on Dissolution of Cilnidipine Nanosuspension

S Subramanian - Asian Journal of Pharmaceutics (AJP), 2020 - asiapharmaceutics.info
Aim: Cilnidipine is a new antihypertensive agent and it is categorized under the
biopharmaceutical Class-II drug. Hence, our perspective is to improve dissolution through in …

[PDF][PDF] A novel technique to enhance dissolution rate of cilnidipine using liquisolid compact and wet granulation

VV Siju, M Soniwala, S Nagar - Int J Pharm Sci Drug Res, 2017 - academia.edu
The main objective of the work was to improve the dissolution rate of the drug, Cilnidipine
(CLD) by using the liquisolid compact technique and wet granulation. Cilnidipine drug is …

Formulation and Evaluation of Cilnidipine Solid Dispersions and Oral Controlled Release Formulations

R Vydana, CSK Bonnoth - Current Trends in Biotechnology and …, 2022 - abap.co.in
The objective of the present study is to improve the solubility of Biopharmaceutical
Classification System (BCS) Class-II drug, Cilnidipine by formulating them as solid …